Localized stage non-Hodgkin's lymphoma of the testis: a retrospective study of 16 cases.

M Ostronoff, C Soussain, E Zambon, A Moran, J P Droz, J Bosq, C Bayle, J M Cosset, M Hayat
{"title":"Localized stage non-Hodgkin's lymphoma of the testis: a retrospective study of 16 cases.","authors":"M Ostronoff,&nbsp;C Soussain,&nbsp;E Zambon,&nbsp;A Moran,&nbsp;J P Droz,&nbsp;J Bosq,&nbsp;C Bayle,&nbsp;J M Cosset,&nbsp;M Hayat","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The present report concerns a retrospective study of 16 patients with localized intermediate- or high-grade non-Hodgkin's lymphoma of the testis treated in one institution from 1973 to 1990. Ann Arbor stage of disease was IE in 11 and IIE in 5 cases. All except one patient underwent initial inguinal orchidectomy, 11 were disease free after surgery and 12 received inverted Y radiation therapy. All patients achieved a complete remission (CR). Relapse occurred in 8 of 9 patients who did not receive initial chemotherapy, but in only 3 of 7 patients initially treated with chemotherapy including anthracyclins. In 3 cases relapse was confined to the CNS, while diffuse relapse in 8 others included 4 cases of CNS involvement. Eight patients are now alive in CR (5 in first CR, 1 in second CR and 2 in third CR) with a median follow-up of 68.5 months (range 54-101). Chemotherapy thus emerges as the initial treatment of preference for localized testicular lymphoma. Therapy should be preceded by a thorough assessment of the stage of disease and due to the high frequency of CNS relapse, CNS prophylaxis should be considered for all patients.</p>","PeriodicalId":19366,"journal":{"name":"Nouvelle revue francaise d'hematologie","volume":"37 5","pages":"267-72"},"PeriodicalIF":0.0000,"publicationDate":"1995-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nouvelle revue francaise d'hematologie","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The present report concerns a retrospective study of 16 patients with localized intermediate- or high-grade non-Hodgkin's lymphoma of the testis treated in one institution from 1973 to 1990. Ann Arbor stage of disease was IE in 11 and IIE in 5 cases. All except one patient underwent initial inguinal orchidectomy, 11 were disease free after surgery and 12 received inverted Y radiation therapy. All patients achieved a complete remission (CR). Relapse occurred in 8 of 9 patients who did not receive initial chemotherapy, but in only 3 of 7 patients initially treated with chemotherapy including anthracyclins. In 3 cases relapse was confined to the CNS, while diffuse relapse in 8 others included 4 cases of CNS involvement. Eight patients are now alive in CR (5 in first CR, 1 in second CR and 2 in third CR) with a median follow-up of 68.5 months (range 54-101). Chemotherapy thus emerges as the initial treatment of preference for localized testicular lymphoma. Therapy should be preceded by a thorough assessment of the stage of disease and due to the high frequency of CNS relapse, CNS prophylaxis should be considered for all patients.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
睾丸局部分期非霍奇金淋巴瘤16例回顾性分析。
本报告涉及一项回顾性研究,从1973年到1990年在一家机构治疗的16例局限性中、高级非霍奇金睾丸淋巴瘤患者。Ann Arbor分期为IE 11例,IE 5例。除1例患者外,其余患者均行初始腹股沟睾丸切除术,11例术后无病,12例接受倒Y放射治疗。所有患者均获得完全缓解(CR)。未接受初始化疗的9例患者中有8例复发,但最初接受蒽环类药物化疗的7例患者中只有3例复发。3例复发局限于中枢神经系统,8例弥漫性复发包括4例中枢神经系统受累。8例患者目前在CR中存活(5例为第一次CR, 1例为第二次CR, 2例为第三次CR),中位随访时间为68.5个月(范围54-101)。因此,化疗成为局部睾丸淋巴瘤首选的初始治疗方法。治疗前应全面评估疾病的分期,由于中枢神经系统复发的频率很高,应考虑对所有患者进行中枢神经系统预防。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
[Acute myelomonocytic leukemia with abnormal eosinophils]. [Myelodysplastic syndromes]. XIVth Congress of the French Society of Hematology. Paris, France, February 3-4, 1995. Abstracts. [Eprex: historical record and development]. [Erythropoietin and delayed taking of autologous blood: from physiologic secretion to the rationale for exogenous supplementation].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1